Rubicon Research

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE506V01022
  • NSEID: RUBICON
  • BSEID: 544578
INR
1,272.25
-42.15 (-3.21%)
BSENSE

Jun 03, 03:30 PM

BSE+NSE Vol: 20.15 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Net Sales
1,753.96
1,284.27
853.89
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,753.96
1,284.27
853.89
Raw Material Cost
615.10
453.60
247.92
Purchase of Finished goods
91.32
79.02
88.52
(Increase) / Decrease In Stocks
-150.37
-157.22
-53.01
Employee Cost
256.29
211.05
125.34
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
541.38
433.57
290.52
Total Expenditure (Excl Depreciation)
1,353.72
1,020.01
699.30
Operating Profit (PBDIT) excl Other Income
400.24
264.26
154.59
Other Income
7.73
3.63
18.50
Operating Profit (PBDIT)
407.97
267.89
173.09
Interest
42.17
36.78
31.26
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
365.80
231.11
141.83
Depreciation
45.26
36.59
38.97
Profit Before Tax
320.53
194.52
102.86
Tax
73.80
60.16
11.85
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
246.74
134.36
91.01
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
246.74
134.36
91.01
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
246.74
134.36
91.01
Equity Capital
16.51
15.41
15.21
Face Value
1.0
1.0
1.0
Reserves
1,272.31
525.57
369.79
Earnings per share (EPS)
14.94
8.72
5.98
Diluted Earnings per share
15.31
8.68
5.91
Operating Profit Margin (Excl OI)
22.82%
20.58%
18.1%
Gross Profit Margin
20.86%
18.0%
16.61%
PAT Margin
14.07%
10.46%
10.66%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 36.57% vs 50.40% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is 83.64% vs 47.63% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 51.46% vs 70.94% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 14.65% vs 17.66% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Rubicon Research With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,753.96
2,022.99
-269.03
-13.30%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,753.96
2,022.99
-269.03
-13.30%
Raw Material Cost
615.10
819.76
-204.66
-24.97%
Purchase of Finished goods
91.32
0.00
91.32
(Increase) / Decrease In Stocks
-150.37
-64.26
-86.11
-134.00%
Employee Cost
256.29
341.14
-84.85
-24.87%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
191.62
-191.62
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
541.38
160.23
381.15
237.88%
Total Expenditure (Excl Depreciation)
1,353.72
1,448.49
-94.77
-6.54%
Operating Profit (PBDIT) excl Other Income
400.24
574.50
-174.26
-30.33%
Other Income
7.73
30.17
-22.44
-74.38%
Operating Profit (PBDIT)
407.97
604.67
-196.70
-32.53%
Interest
42.17
23.95
18.22
76.08%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
365.80
580.72
-214.92
-37.01%
Depreciation
45.26
91.74
-46.48
-50.66%
Profit Before Tax
320.53
488.98
-168.45
-34.45%
Tax
73.80
124.98
-51.18
-40.95%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
246.74
364.00
-117.26
-32.21%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
246.74
364.00
-117.26
-32.21%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
246.74
364.00
-117.26
-32.21%
Equity Capital
16.51
12.90
3.61
27.98%
Face Value
1.00
10.00
0.00
Reserves
1,272.31
1,860.73
-588.42
-31.62%
Earnings per share (EPS)
14.94
282.17
-267.23
-94.71%
Diluted Earnings per share
15.31
283.71
-268.40
-94.60%
Operating Profit Margin (Excl OI)
22.82%
28.40%
0.00
-5.58%
Gross Profit Margin
20.86%
28.71%
0.00
-7.85%
PAT Margin
14.07%
17.99%
0.00
-3.92%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,753.96 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 36.57% vs 50.40% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 246.74 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 83.64% vs 47.63% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 400.24 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 51.46% vs 70.94% in Mar 2025

Annual - Interest
Interest 42.17 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 14.65% vs 17.66% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.82%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has improved from Mar 2025